Open Technique Interpectoral Catheter for Postoperative Analgesia in Modified Radical Mastectomy
Primary Purpose
Mammary Cancer
Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
catheter
iv analgesia
Sponsored by
About this trial
This is an interventional supportive care trial for Mammary Cancer focused on measuring postoperative analgsia, peripheral block catheter, modified radical mastectomy
Eligibility Criteria
Inclusion Criteria:
- American Society of Americans Class I-II
Exclusion Criteria:
- male
- allergy to local anesthetics or
- anticoagulant drug use
- central or peripheric nerve disease
- pregnancy
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Active Comparator
Arm Label
iv analgesia
catheter group
Arm Description
patients were given intravenously 100 mg of tramadol (contramal) 30 minutes before extubation after modified radical mastectomy.
patients were placed a catheter under clavipectoral fascia and 30 ml of local anesthetic solution were given via catheter for postoperative analgesia
Outcomes
Primary Outcome Measures
VAS scores
patients were asked to give a point between 0 to 10 for their pain level. 0 is no pain, 10 is the strongest pain.
VAS scores
patients were asked to give a point between 0 to 10 for their pain level. 0 is no pain, 10 is the strongest pain.
VAS scores
patients were asked to give a point between 0 to 10 for their pain level. 0 is no pain, 10 is the strongest pain.
VAS scores
patients were asked to give a point between 0 to 10 for their pain level. 0 is no pain, 10 is the strongest pain.
Secondary Outcome Measures
VAS scores
patients were asked to give a point between 0 to 10 for their pain level. 0 is no pain, 10 is the strongest pain.
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT03204708
Brief Title
Open Technique Interpectoral Catheter for Postoperative Analgesia in Modified Radical Mastectomy
Official Title
Evaluation of the Postoperative Analgesic Efficacy of Catheter Placed Interpectoral Region Via Open Technique in Patients Undergoing Modified Radical Mastectomy
Study Type
Interventional
2. Study Status
Record Verification Date
February 2018
Overall Recruitment Status
Completed
Study Start Date
April 15, 2016 (Actual)
Primary Completion Date
February 15, 2017 (Actual)
Study Completion Date
February 28, 2017 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Istanbul University
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
patients undergoing modified radical mastectomy were divided into two groups. patients in catheter group were placed a catheter with open technique by the surgeon in the pectoral area. thirty minutes before extubation %1 lidocain 10 ml, %0.5 bupivacain 10 ml and 10 ml %0.9 sodium chloride were given through the catheter for postoperative analgesia. patients in iv analgesia group were given 100 mg tramadol iv 30 minutes before extubation. visual analog pain scale (VAS) scores, rescue analgesic requirement, complications were recorded and compared between two groups 1, 6, 12, 24 hours and 90 days after surgery.
Detailed Description
patients undergoing modified radical mastectomy were divided into two groups by computer. patients in catheter group were placed a catheter under clavipectoral fascia in the neighbourhood of nervus thoracicus longus, nervus thoracodorsalis, nervus pectoralis lateralis, nervus pectoralis medialis at the 1/3 lateral part of clavicula. solution included 10 ml of %0.5 bupivacain, %1 lidocain, 10 ml %0.9 sodium chloride totally 30 ml were given via the catheter for postoperative analgesia at the end of surgery. patients in iv analgesia group were given 100 mg tramadol iv 30 minutes before extubation. Patients in both groups were given dexketoprofen 50 mg iv if the VAS score was over 4. VAS scores, rescue analgesic requirement and timing, complications were recorded and compared between groups 1, 6, 12, 24 hours and 90 days after surgery.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Mammary Cancer
Keywords
postoperative analgsia, peripheral block catheter, modified radical mastectomy
7. Study Design
Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
86 (Actual)
8. Arms, Groups, and Interventions
Arm Title
iv analgesia
Arm Type
Active Comparator
Arm Description
patients were given intravenously 100 mg of tramadol (contramal) 30 minutes before extubation after modified radical mastectomy.
Arm Title
catheter group
Arm Type
Active Comparator
Arm Description
patients were placed a catheter under clavipectoral fascia and 30 ml of local anesthetic solution were given via catheter for postoperative analgesia
Intervention Type
Device
Intervention Name(s)
catheter
Intervention Description
catheter was placed under clavipectoral fascia by open technique by surgeon at the 1/3 lateral part of clavicula neighbourhood of nervus thoracicus longus, nervus thoracodorsalis, nervus pectoralis lateralis, nervus pectoralis medialis
Intervention Type
Drug
Intervention Name(s)
iv analgesia
Intervention Description
patients were given 100 ml of tramadol 30 minutes before extubation
Primary Outcome Measure Information:
Title
VAS scores
Description
patients were asked to give a point between 0 to 10 for their pain level. 0 is no pain, 10 is the strongest pain.
Time Frame
1 hour after operation
Title
VAS scores
Description
patients were asked to give a point between 0 to 10 for their pain level. 0 is no pain, 10 is the strongest pain.
Time Frame
6 hours after operation
Title
VAS scores
Description
patients were asked to give a point between 0 to 10 for their pain level. 0 is no pain, 10 is the strongest pain.
Time Frame
12 hours after operation
Title
VAS scores
Description
patients were asked to give a point between 0 to 10 for their pain level. 0 is no pain, 10 is the strongest pain.
Time Frame
24 hours after operation
Secondary Outcome Measure Information:
Title
VAS scores
Description
patients were asked to give a point between 0 to 10 for their pain level. 0 is no pain, 10 is the strongest pain.
Time Frame
3 months after operation
Other Pre-specified Outcome Measures:
Title
rescue analgesic requirement
Description
patients whose VAS scores were over 4 were given 50 mg of dexketoprofen in Group I, 10 ml %0.25 bupivacain in Group II
Time Frame
1, 6, 12 and 24 hours after operation
10. Eligibility
Sex
Female
Gender Based
Yes
Gender Eligibility Description
breast cancer
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
American Society of Americans Class I-II
Exclusion Criteria:
male
allergy to local anesthetics or
anticoagulant drug use
central or peripheric nerve disease
pregnancy
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
cigdem akyol beyoglu, MD
Organizational Affiliation
Istanbul University
Official's Role
Study Director
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Open Technique Interpectoral Catheter for Postoperative Analgesia in Modified Radical Mastectomy
We'll reach out to this number within 24 hrs